Bolstering Community Cooperation in Ebola Resurgence Protocols: Combining Field Blood Draw and Point-of-Care Diagnosis

1. World Health Organization. The Ebola outbreak in Liberia is over. World Health Organization; 3 Jun 2015 [cited 16 Jun 2016]. http://www.who.int/mediacentre/news/statements/2015/liberia-ends-ebola/en/http://www.who.int/mediacentre/news/statements/2015/liberia-ends-ebola/en/

2. Uyeki TM, Erickson BR, Brown S, McElroy AK, Cannon D, Gibbons A, et al. Ebola Virus Persistence in Semen of Male Survivors. Clin Infect Dis. 2016;62:1552–1555. doi: 10.1093/cid/ciw202 27045122

3. Deen GF, Knust B, Broutet N, Sesay FR, Formenty P, Ross C, et al. Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors—Preliminary Report. N Engl J Med. Epub 2015 Oct 14.

4. Varkey JB, Shantha JG, Crozier I, Kraft CS, Lyon GM, Mehta AK, et al. Persistence of Ebola Virus in Ocular Fluid during Convalescence. N Engl J Med. 2015;372:2423–2427. doi: 10.1056/NEJMoa1500306 25950269

5. Rodriguez LL, De Roo A, Guimard Y, Trappier SG, Sanchez A, Bressler D, et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179 Suppl 1:S170–6.

6. Mate SE, Kugelman JR, Nyenswah TG, Ladner JT, Wiley MR, Cordier-Lassalle T, et al. Molecular Evidence of Sexual Transmission of Ebola Virus. N Engl J Med. 2015;373:2448–2454. doi: 10.1056/NEJMoa1509773 26465384

7. World Health Organization. Clinical care for survivors of Ebola virus disease; 2016 [cited 20 Jun 2016]. http://www.who.int/csr/resources/publications/ebola/guidance-survivors/en/http://www.who.int/csr/resources/publications/ebola/guidance-survivors/en/

8. World Health Organization. Surveillance strategy during Phase 3 of the Ebola response. World Health Organization; 2016 [cited 21 Oct 2016]. http://www.who.int/csr/resources/publications/ebola/surveillance-strategy-phase3/en/http://www.who.int/csr/resources/publications/ebola/surveillance-strategy-phase3/en/

9. Gleason B, Redd J, Kilmarx P, Sesay T, Bayor F, Mozalevskis A, et al. Establishment of an Ebola Treatment Unit and Laboratory—Bombali District, Sierra Leone, July 2014–January 2015. MMWR Morb Mortal Wkly Rep. 2015;64:1108–1111. doi: 10.15585/mmwr.mm6439a4 26447483

10. Zachariah R, Harries AD. The WHO clinical case definition for suspected cases of Ebola virus disease arriving at Ebola holding units: reason to worry? Lancet Infect Dis. 2015;15:989–990. doi: 10.1016/S1473-3099(15)00160-7 26213247

11. Vogt F, Fitzpatrick G, Patten G, van den Bergh R, Stinson K, Pandolfi L, et al. Assessment of the MSF triage system, separating patients into different wards pending Ebola virus laboratory confirmation, Kailahun, Sierra Leone, July to September 2014. Euro Surveill. 2015;20.

12. Bell BP, Damon IK, Jernigan DB, Kenyon TA, Nichol ST, O’Connor JP, et al. Overview, Control Strategies, and Lessons Learned in the CDC Response to the 2014–2016 Ebola Epidemic. MMWR Suppl. 2016;65:4–11.

13. Calain P, Poncin M. Reaching out to Ebola victims: Coercion, persuasion or an appeal for self-sacrifice? Soc Sci Med. 2015;147:126–133. doi: 10.1016/j.socscimed.2015.10.063 26561947

14. Thiam S, Delamou A, Camara S, Carter J, Lama EK, Ndiaye B, et al. Challenges in controlling the Ebola outbreak in two prefectures in Guinea: why did communities continue to resist? Pan Afr Med J. 2015;22 Suppl 1:22.

15. World Health Organization. Factors that contributed to undetected spread of the Ebola virus and impeded rapid containment. World Health Organization; 2015 [cited 21 Oct 2016]. http://www.who.int/csr/disease/ebola/one-year-report/factors/en/http://www.who.int/csr/disease/ebola/one-year-report/factors/en/

16. Briand S, Bertherat E, Cox P, Formenty P, Kieny M-P, Myhre JK, et al. The international Ebola emergency. N Engl J Med. 2014;371:1180–1183. doi: 10.1056/NEJMp1409858 25140855

17. Hall RCW, Hall RCW, Chapman MJ. The 1995 Kikwit Ebola outbreak: lessons hospitals and physicians can apply to future viral epidemics. Gen Hosp Psychiatry. 2008;30:446–452. doi: 10.1016/j.genhosppsych.2008.05.003 18774428

18. Callaghan M, Ford N, Schneider H. A systematic review of task- shifting for HIV treatment and care in Africa. Hum Resour Health. 2010;8:8. doi: 10.1186/1478-4491-8-8 20356363

19. Pai NP, Vadnais C, Denkinger C, Engel N, Pai M. Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries. PLoS Med. 2012;9:e1001306. doi: 10.1371/journal.pmed.1001306 22973183

20. Fallah M, Dahn B, Nyenswah TG, Massaquoi M, Skrip LA, Yamin D, et al. Interrupting Ebola Transmission in Liberia Through Community-Based Initiatives. Ann Intern Med. 2016;164:367–369. doi: 10.7326/M15-1464 26746879

21. Jansen van Vuren P, Grobbelaar A, Storm N, Conteh O, Konneh K, Kamara A, et al. Comparative Evaluation of the Diagnostic Performance of the Prototype Cepheid GeneXpert Ebola Assay. J Clin Microbiol. 2016;54:359–367. doi: 10.1128/JCM.02724-15 26637383

22. Fitzpatrick G, Vogt F, Moi Gbabai OB, Decroo T, Keane M, De Clerck H, et al. The Contribution of Ebola Viral Load at Admission and Other Patient Characteristics to Mortality in a Médecins Sans Frontières Ebola Case Management Centre, Kailahun, Sierra Leone, June–October 2014. J Infect Dis. 2015;212:1752–1758. doi: 10.1093/infdis/jiv304 26002981

23. World Health Organization. Urgently needed: rapid, sensitive, safe and simple Ebola diagnostic tests [cited 20 Oct 2016]. http://www.who.int/mediacentre/news/ebola/18-november-2014-diagnostics/en/http://www.who.int/mediacentre/news/ebola/18-november-2014-diagnostics/en/

24. Nouvellet P, Garske T, Mills HL, Nedjati-Gilani G, Hinsley W, Blake IM, et al. The role of rapid diagnostics in managing Ebola epidemics. Nature. 2015;528:S109–16. doi: 10.1038/nature16041 26633764

25. Broadhurst MJ, Kelly JD, Miller A, Semper A, Bailey D, Groppelli E, et al. ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study. Lancet. 2015;386:867–874. doi: 10.1016/S0140-6736(15)61042-X 26119838

26. Semper AE, Broadhurst MJ, Richards J, Foster GM, Simpson AJH, Logue CH, et al. Performance of the GeneXpert Ebola Assay for Diagnosis of Ebola Virus Disease in Sierra Leone: A Field Evaluation Study. PLoS Med. 2016;13:e1001980. doi: 10.1371/journal.pmed.1001980 27023868

27. Van den Bergh R, Chaillet P, Sow MS, Amand M, van Vyve C, Jonckheere S, et al. Feasibility of Xpert Ebola Assay in Médecins Sans Frontières Ebola Program, Guinea. Emerg Infect Dis. 2016;22:210–216. doi: 10.3201/eid2202.151238 26812466

28. World Health Organization. WHO Emergency Use Assessment and Listing for EVD IVDs, Public Report; [cited 30 Oct 2016]. World Health Organization; http://www.who.int/medicines/ebola-treatment/150508FinalPublicReportExpertEbola_Cepheid.pdfhttp://www.who.int/medicines/ebola-treatment/150508FinalPublicReportExpertEbola_Cepheid.pdf

29. Trombley AR, Wachter L, Garrison J, Buckley-Beason VA, Jahrling J, Hensley LE, et al. Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am J Trop Med Hyg. 2010;82:954–960. doi: 10.4269/ajtmh.2010.09-0636 20439981

30. Blackley DJ, Wiley MR, Ladner JT, Fallah M, Lo T, Gilbert ML, et al. Reduced evolutionary rate in reemerged Ebola virus transmission chains. Science Advances. American Association for the Advancement of Science; 2016;2:e1600378. doi: 10.1126/sciadv.1600378 27386513

31. Yamin D, Gertler S, Ndeffo-Mbah ML, Skrip LA, Fallah M, Nyenswah TG, et al. Effect of Ebola progression on transmission and control in Liberia. Ann Intern Med. 2015;162:11–17. doi: 10.7326/M14-2255 25347321

32. Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet. 2015;386:857–866. doi: 10.1016/S0140-6736(15)61117-5 26248676

33. Huttner A, Dayer J- A, Yerly S, Combescure C, Auderset F, Desmeules J, et al. The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial. Lancet Infect Dis. Elsevier; 2015;15:1156–1166. doi: 10.1016/S1473-3099(15)00154-1 26248510

34. Zon H, Petesch C. Post-Ebola, West Africans flock back to bushmeat, with risk. In: The Big Story. 1 Sep 2016. http://bigstory.ap.org/article/2ff0034f651a4e229c6d9a74b21bc80f/post-ebola-west-africans-flock-back-bush-meat-risk. Accessed 30 Dec 2016.http://paperpile.com/b/UeKI6o/xVkq

35. Alexander KA, Sanderson CE, Marathe M, Lewis BL, Rivers CM, Shaman J, et al. What factors might have led to the emergence of Ebola in West Africa? PLoS Negl Trop Dis. 2015;9:e0003652. doi: 10.1371/journal.pntd.0003652 26042592

36. Walker NF, Brown CS, Youkee D, Baker P, Williams N, Kalawa A, et al. Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, Western Area, Sierra Leone, January to February 2015. Euro Surveill. 2015;20.

37. Kateh F, Nagbe T, Kieta A, Barskey A, Gasasira AN, Driscoll A, et al. Rapid response to Ebola outbreaks in remote areas—Liberia, July-November 2014. MMWR Morb Mortal Wkly Rep. 2015;64:188–192. http://www.ncbi.nlm.nih.gov/pubmed/25719682http://www.ncbi.nlm.nih.gov/pubmed/25719682. 25719682